Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet light

Transfusion

Volumn 49, Issue 10, 2009, Pages 2144-2151

  Mohr, Harald ^a   Gravemann, Ute ^a   Müller, Thomas H ^a  

^a Institute Springe   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; FRESH FROZEN PLASMA;

ARTICLE; EQUIPMENT; HUMAN IMMUNODEFICIENCY VIRUS 1; IRRADIATION; PLASMA; STORAGE TEMPERATURE; ULTRAVIOLET RADIATION; VIRUS CONCENTRATION; VIRUS INACTIVATION;

BLOOD PRESERVATION; BLOOD PROTEINS; HUMANS; IMMUNOASSAY; PLASMA; STERILIZATION; ULTRAVIOLET RAYS; VIRUSES;

EID: 70350435887     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02234.x     Document Type: Article

References (45)

1. Kallenbach NR, Cornelius PA, Negus D, Montgomerie D, Englander S. Inactivation of viruses by ultraviolet light. Curr Stud Hematol Blood Transfus 1989 56 : 70 82.
2. Degiorgi CF, Fernandez RO, Pizarro RA. Ultraviolet-B lethal damage on Pseudomonas aeruginosa. Curr Microbiol 1996 33 : 141 6.
3. Hirayama J, Abe H, Ikebuchi K, Horiuchi M, Shinagawa M, Kamo N, Sekiguchi S. Virus inactivation in superoxide dismutase preparations by ultraviolet light irradiation. Biol Pharm Bull 1998 21 : 621 3.
4. Otaki M, Okuda A, Tajima K, Iwasaki T, Kinoshita S, Ohgaki S. Inactivation differences of microorganisms by low pressure UV and pulsed xenon lamps. Water Sci Technol 2003 47 : 185 90.
5. Kurth J, Waldmann R, Heith J, Mausbach K, Burian R. Efficient inactivation of viruses and mycoplasma in animal sera using UVC irradiation. Dev Biol Stand 1999 99 : 111 8.
6. Sinha RP, Hader DP. UV-induced DNA damage and repair: a review. Photochem Photobiol Sci 2002 1 : 225 36.
7. Cadet J, Sage E, Douki T. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 2005 571 : 3 17. (Pubitemid 40313428)
8. Pelletier JP, Transue S, Snyder EL. Pathogen inactivation techniques. Best Pract Res Clin Haematol 2006 19 : 205 42.
9. Mohr H, Lambrecht B, Selz A. Photodynamic virus inactivation of blood components. Immunol Invest 1995 24 : 73 85.
10. Lin L, Hanson CV, Alter HJ, Jauvin V, Bernard KA, Murthy KK, Metzel P, Corash L. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005 45 : 580 90.
11. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004 44 : 877 85.
12. Gaffney DK, Sieber F. The role of serum and serum components in the merocyanine 540-sensitized photoinactivation of K562 leukemia cells. Biochim Biophys Acta 1992 1117 : 321 5.
13. Lin L, Conlan MG, Tessman J, Cimino G, Porter S. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment. Transfusion 2005 45 : 1610 20.
14. Hart H, Reid K, Hart W. Inactivation of viruses during ultraviolet light treatment of human intravenous immunoglobulin and albumin. Vox Sang 1993 64 : 82 8.
15. Chin S, Williams B, Gottlieb P, Margolis-Nunno H, Ben-Hur E, Hamman J, Jin R, Dubovi E, Horowitz B. Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: protection of proteins by antioxidants. Blood 1995 86 : 4331 6.
16. Caillet-Fauquet P, Di Giambattista M, Draps ML, Sandras F, Branckaert T, de Launoit Y, Laub R. Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19. J Virol Methods 2004 118 : 131 9.
17. Li Q, Macdonald S, Bienek C, Foster PR, Macleod AJ. Design of a UV-C irradiation process for the inactivation of viruses in protein solutions. Biologicals 2005 33 : 101 10.
18. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Haemotherapie), gemäß Transfusionsgesetz der Bundesärztekammer und des Paul-Ehrlich-Instituts, Koeln : Deutscher Aerzteverlag 2005.
19. Mohr H, Tolksdorf F, Walker W, Müller TH. Polyolefinacetate bags for photodynamic treatment and for storage of platelet concentrates. Vox Sang 2004 87 Suppl 3 : S17 S92.
20. Kaerber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn Schmiedebergs. Arch Exp Pathol Pharmakol 1931 162 : 480 3.
21. Spearman C. The method of "right and wrong cases" ("constant stimuli") without Gauss's formulae. Br J Psychol 1908 2 : 277 82.
22. Oliphant JW, Hollaender A. Homologous serum jaundice: experimental inactivation of etiologic agent in serum by ultraviolet irradiation. Publ Health Rep 1946 61 : 598 600.
23. Wolf AM, Jack M, Fitzpatrick WJ, Schwartz SO, Levinson SO. Ultraviolet irradiation of human plasma to control homologous serum jaundice. JAMA 1947 135 : 476 7.
24. Wang J, Mauser A, Chao SF, Remington K, Treckmann R, Kaiser K, Pifat D, Hotta J. Virus inactivation and protein recovery in a novel ultraviolet-C reactor. Vox Sang 2004 86 : 230 8.
25. Calkins J, Wheeler JS, Keller CI, Colley E, Hazle JD. Comparative ultraviolet action spectra (254-320 nm) of five "wild-type" eukaryotic microorganisms and Escherichia coli. Radiat Res 1988 114 : 307 18.
26. van Prooijen HC, van Marwijk Kooy M, van Weelden H, Aarts-Riemens MI, Borghuis L, Akkerman JW. Evaluation of a new UVB source for irradiation of platelet concentrates. Br J Haematol 1990 75 : 573 7.
27. Capon SM, Sacher RA, Deeg HJ. Effective ultraviolet irradiation of platelet concentrates in teflon bags. Transfusion 1990 30 : 678 81.
28. Lytle CD, Sagripanti JL. Predicted inactivation of viruses of relevance to biodefense by solar radiation. J Virol 2005 79 : 14244 52.
29. Saleh SM, Poidinger M, Mackenzie JS, Broom AK, Lindsay MD, Hall RA. Complete genomic sequence of the Australian south-west genotype of Sindbis virus: comparisons with other Sindbis strains and identification of a unique deletion in the 3′-untranslated region. Virus Genes 2003 26 : 317 27.
30. Lawson ND, Stillman EA, Whitt MA, Rose JK. Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 1995 92 : 4477 81.
31. Mohr H. Inactivation of viruses in human plasma. Methods Enzymol 2000 319 : 207 16.
32. Note for guidance on virus validation studies: the design, contribution and interpretation of studies validating the inactivation and removal of viruses. London : The European Agency for the Evaluation of Medicinal Products, Committee for the Proprietary Medicinal Products 1996.
33. Terpstra FG, van 't Wout AB, Schuitemaker H, van Engelenburg FA, Dekkers DW, Verhaar R, de Korte D, Verhoeven AJ. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates. Transfusion 2008 48 : 304 13.
34. Henderson EE, Tudor G, Yang J-Y. Inactivation of the human immunodeficiency virus Type 1 (HIV-1) by ultraviolet and X irradiation. Rad Res 1992 131 : 169 76.
35. Stramer SL. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 2007 131 : 702 7.
36. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007 47 : 316 25.
37. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ German Red Cross NAT Study Group. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C, and hepatitis B virus. Transfusion 2008 48 : 1558 66.
38. Sugawara H, Motokawa R, Abe H, Yamaguchi M, Yamada-Ohnishi Y, Hirayama J, Sakata H, Sato S, Kamo N, Ikebuchi K, Ikeda H. Inactivation of parvovirus B19 in coagulation factor concentrates by UVC radiation: assessment by an in vitro infectivity assay using CFU-E derived from peripheral blood CD34+ cells. Transfusion 2001 41 : 456 61.
39. Pattison DI, Davies MJ. Actions of ultraviolet light on cellular structures. EXS 2006 96 : 131 57.
40. Chan HL, Gaffney PR, Waterfield MD, Anderle H, Peter Matthiessen H, Schwarz HP, Turecek PL, Timms JF. Proteomic analysis of UVC irradiation-induced damage of plasma proteins: serum amyloid P component as a major target of photolysis. FEBS Lett 2006 580 : 3229 36.
41. Michnik A, Michalik K, Drzazga Z. Effect of UVC radiation on conformational restructuring of human serum albumin. J Photochem Photobiol B 2008 90 : 170 8.
42. Wu W, Sinha D, Shikov S, Yip CK, Walz T, Billings PC, Lear JD, Walsh PN. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin and factor XIa. J Biol Chem 2008 283 : 18655 64.
43. Singh Y, Sawyer LS, Pinkoski LS, Dupuis KW, Hsu JC, Lin L, Corash L. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006 46 : 1168 77.
44. Goodrich RP, Edrich RA, Li J, Seghatchian J. The Mirasoltrade mark PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006.
45. Solheim BG, Seghatchian J. Update on pathogen reduction technology for therapeutic plasma: an overview. Transfus Apher Sci 2006.